Cholestyramine Powder for Suspension Clinical Trials

• Study of Asthma in Patients of African Descent
  ClinicalTrials.gov Identifier: NCT00102765 - Active, not recruiting
  Asthma
  
• TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00576251 - Recruiting
  Ocular Inflammation Associated With Blepharaconjunctivitis
  
• Effects of Garlic Supplements On Drug Metabolism
  ClinicalTrials.gov Identifier: NCT00122889 - Recruiting
  Healthy
  
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
  Chronic Hepatitis B
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex
  
• Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux
  ClinicalTrials.gov Identifier: NCT00004487 - Active, not recruiting
  Vesicoureteral Reflux
  
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
  ClinicalTrials.gov Identifier: NCT00475371 - Active, not recruiting
  Diabetes Mellitus, Type 2; Healthy Males
  
• A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children
  ClinicalTrials.gov Identifier: NCT00297206 - Active, not recruiting
  Herpes Simplex
  
• Pediatric Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00034736 - Completed
  Pneumonia
  
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00232648 - Active, not recruiting
  Asthma
  
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418AM4)
  ClinicalTrials.gov Identifier: NCT00394355 - Recruiting
  Asthma
  
• A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD
  ClinicalTrials.gov Identifier: NCT00446667 - Recruiting
  COPD; Exacerbation
  
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567918 - Active, not recruiting
  Keratoconjunctivitis; Conjunctivitis
  
• A Study of the Equivalent Effectiveness of 400 Mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)
  ClinicalTrials.gov Identifier: NCT00521599 - Recruiting
  Asthma
  
• Study Of Asthma And Genetics
  ClinicalTrials.gov Identifier: NCT00102882 - Completed
  Asthma
  
• Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
  ClinicalTrials.gov Identifier: NCT00405730 - Active, not recruiting
  Cataract Surgery
  
• The Effect of Silicone Suspension on Standing Balance for Transfemoral Amputees
  ClinicalTrials.gov Identifier: NCT00400127 - Recruiting
  Amputee
  
• Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00446680 - Recruiting
  Cystic Fibrosis
  
• Bronchodilatory Efficacy of a Single Dose QMF149 Via a Multiple-Dose Dry Powder Inhaler (MDDPI) in Adult Asthma Patients
  ClinicalTrials.gov Identifier: NCT00556673 - Recruiting
  Asthma
  
• Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00475319 - Recruiting
  Dry Eye Syndromes
  
• Clinical Trial for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
  Prostate Cancer
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Efficacy of Tiotropium in Patients of African Descent with Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00106821 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
  Hepatitis C
  
• Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
  ClinicalTrials.gov Identifier: NCT00426595 - Recruiting
  Gastreoesophageal Reflux Disease
  
• Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD
  ClinicalTrials.gov Identifier: NCT00259012 - Recruiting
  Gastroesophageal Reflux
  
• Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
  ClinicalTrials.gov Identifier: NCT00426920 - Not yet recruiting
  Diabetes Mellitus
  
• Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
  ClinicalTrials.gov Identifier: NCT00378677 - Recruiting
  Lung Transplantation; Bronchiolitis Obliterans
  
• Dose-Ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
  ClinicalTrials.gov Identifier: NCT00504426 - Recruiting
  Pain Due to Osteoporosis
  
• Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00355888 - Recruiting
  Cancer
  
• A Phase II Study of DMP 115 to Assess Focal Liver Lesions
  ClinicalTrials.gov Identifier: NCT00162058 - Active, not recruiting
  Liver Disease
  
• Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00114634 - Recruiting
  
  
• Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00095121 - Active, not recruiting
  Chronic Hepatitis B
  
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00388505 - Recruiting
  Cystic Fibrosis
  
• Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation
  ClinicalTrials.gov Identifier: NCT00502021 - Not yet recruiting
  Morbid Obesity; Atherosclerosis; Systemic Inflammation
  
• Budesonide Inhalation Suspension for Acute Asthma in Children
  ClinicalTrials.gov Identifier: NCT00393367 - Recruiting
  Asthma; Acute Asthma; Reactive Airway Exacerbation
  
• Posterior IVS Versus Sacrospinous Suspension in Vaginal Vault Prolapse Repair
  ClinicalTrials.gov Identifier: NCT00153231 - Recruiting
  Vaginal Prolapse
  
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527501 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
  ClinicalTrials.gov Identifier: NCT00346827 - Not yet recruiting
  Parkinson's Disease
  
• Effect of Sling Suspension Exercises in Proprioception of Patients with Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00154765 - Completed
  Osteoarthritis
  
• Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
  ClinicalTrials.gov Identifier: NCT00125346 - Suspended
  Cystic Fibrosis
  
• A Phase 4 Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease.
  ClinicalTrials.gov Identifier: NCT00162370 - Recruiting
  Coronary Artery Disease; Heart Disease
  
• Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
  ClinicalTrials.gov Identifier: NCT00002112 - Completed
  Candidiasis, Oral; HIV Infections
  
• Effect of Arista Powder on Bleeding in Reductive Mammary Surgery
  ClinicalTrials.gov Identifier: NCT00227084 - Completed
  Mammaplasty
  
• Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)
  ClinicalTrials.gov Identifier: NCT00443482 - Completed
  Asthma
  
• Harvard Atherosclerosis Reversibility Project (HARP)
  ClinicalTrials.gov Identifier: NCT00000461 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Vacuum Suspension: Effects On Tissue Oxygenation, Activity and Fit
  ClinicalTrials.gov Identifier: NCT00117793 - Not yet recruiting
  Amputation; Traumatic Amputations; Diabetes; Leg Injuries
  
• Study of Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00001721 - Recruiting
  Abnormalities; Inborn Errors of Metabolism; Mental Retardation; Muscle Hypotonia; Smith Lemli Opitz Syndrome
  
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)
  ClinicalTrials.gov Identifier: NCT00000488 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Post Coronary Artery Bypass Graft (CABG) Study
  ClinicalTrials.gov Identifier: NCT00000463 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
  ClinicalTrials.gov Identifier: NCT00413387 - Completed
  Bronchial Asthma
  
• Metformin Suspension and Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00437333 - Completed
  Polycystic Ovary Syndrome
  
• A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00455130 - Completed
  Cystic Fibrosis
  
• Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
  ClinicalTrials.gov Identifier: NCT00434681 - Completed
  Fever; Pain
  
• Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00403637 - Completed
  Asthma
  
• Dose-Response Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00234078 - Completed
  Dry Eye Syndromes
  
• Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00539890 - Completed
  Diabetes Type 2
  
• A One Year Double-Blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in JRA/JIA
  ClinicalTrials.gov Identifier: NCT00279747 - Completed
  Arthritis, Juvenile Rheumatoid
  
• NHLBI Type II Coronary Intervention Study
  ClinicalTrials.gov Identifier: NCT00000594 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypercholesterolemia, Familial; Myocardial Infarction; Myocardial Ischemia
  
• Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00333255 - Completed
  Cataract
  
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567762 - Completed
  Keratoconjunctivitis; Conjunctivitis
  
• Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)
  ClinicalTrials.gov Identifier: NCT00099515 - Completed
  Diabetes Mellitus, Type 2
  
• Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00465959 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly
  ClinicalTrials.gov Identifier: NCT00225979 - Completed
  Acromegaly
  
• Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.
  ClinicalTrials.gov Identifier: NCT00211484 - Completed
  Age-Related Macular Degenerations.; Subfoveal Neovascularization.
  
• Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
  ClinicalTrials.gov Identifier: NCT00302640 - Completed
  Rotavirus Infection; Adenoviridae Infection; Norovirus Infection
  
• Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients with Graft vs. Host Disease
  ClinicalTrials.gov Identifier: NCT00034645 - Completed
  Mycoses
  
• Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
  ClinicalTrials.gov Identifier: NCT00211432 - Completed
  Pseudovitellium Detachment; Eye Diseases
  
• Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00117182 - Completed
  Lung Diseases, Obstructive
  
• Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00396604 - Completed
  Pulmonary Disease, Chronic Obstructive; COPD; Lung Diseases, Obstructive
  
• Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye
  ClinicalTrials.gov Identifier: NCT00560638 - Completed
  Dry Eye
  
• Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00063128 - Completed
  Diabetes Mellitus, Type 1
  
• A Cross-Over Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Haemodialysis Patients.
  ClinicalTrials.gov Identifier: NCT00267514 - Completed
  Chronic Kidney Disease; Hemodialysis
  
• Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00056654 - Completed
  Prostatic Neoplasms
  
• Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034632 - Completed
  Mycoses
  
• A Safety and Efficacy Study of Intravenous E5564 in Patients with Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00046072 - Completed
  Sepsis; Shock, Septic; Sepsis Syndrome; Septicemia; Infection
  
• Amphotericin B Suspension in Refractory Chronic Sinusitis
  ClinicalTrials.gov Identifier: NCT00425620 - Completed
  Chronic Sinusitis
  
• PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034671 - Completed
  Mycoses
  
• Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
  ClinicalTrials.gov Identifier: NCT00004757 - Completed
  Herpes Simplex
  
• Prophylaxis Trial of Posaconazole vs. Standard Azole Therapy for Neutropenic Patients
  ClinicalTrials.gov Identifier: NCT00044486 - Completed
  Leukemia, Myelocytic, Acute; Myelodysplastic Syndromes; Neutropenia
  
• Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients with Moderate to Severe Keratoconjunctivitis Sicca
  ClinicalTrials.gov Identifier: NCT00128245 - Completed
  Keratoconjunctivitis sicca (dry eye syndrome)
  
• Meloxicam suspension in Juvenile Rheumatoid Arthritis (JRA)
  ClinicalTrials.gov Identifier: NCT00034853 - Completed
  Juvenile Rheumatoid Arthritis
  
• Open-Label Study to Compare Sevelamer Carbonate Powder Dosed Once Per Day to Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Patients With Chronic Kidney Disease on Hemodialysis.
  ClinicalTrials.gov Identifier: NCT00268957 - Completed
  Chronic Kidney Disease; Hemodialysis; Hyperphosphatemia; Chronic Renal Insufficiency; End Stage Renal Disease
  
• Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
  ClinicalTrials.gov Identifier: NCT00211367 - Terminated
  Eye Injuries
  
• Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
  ClinicalTrials.gov Identifier: NCT00211471 - Terminated
  Severe Diabetic Retinopathy; Central Retinal Vein Occlusion; Chronic Inflammation; Infectious Diseases
  
• Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
  ClinicalTrials.gov Identifier: NCT00211406 - Terminated
  Diabetic Retinopathy
  
• Garlic in Hyperlipidemia Caused by HAART
  ClinicalTrials.gov Identifier: NCT00029250 - Terminated
  HIV Infections; Hypercholesterolemia; Hypertriglyceridemia; Hyperglycemia